Impact of a Gratitude-based Intervention in Palliative Care (IPBG)

NCT ID: NCT03703687

Last Updated: 2020-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-27

Study Completion Date

2020-10-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study consisting of mixed-methods, pre-post evaluation of a gratitude intervention (gratitude letter and visit) on palliative care patients and their caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study background and aims:

Gratitude, defined as an "other-oriented" emotion, has shown to impact significantly on many relevant dimensions for palliative care (e.g. well-being, psychological distress and the quality of relationships). Various psychological interventions focused on the enhancement of the feeling of gratitude have been developed and assessed but mostly in non-clinical populations and never taking into account the relationship dimension as an outcome.

The fact that the relational component has never been addressed in interventional studies is all the more surprising since several experimental and non-clinical studies have clearly shown an association between gratitude and feeling of social affiliation, relational commitment, satisfaction with relationships or partner reciprocal maintenance behaviours. These results appear to be very promising for palliative care since interpersonal (and particularly familial) relationships are crucial for palliative care patients: the relational sphere represents a major predictor contributing to both their meaning in life and their quality of life. We hypothesize that considering this concept in palliative care could benefit both the patients and their relatives.

Thus, the purpose of this research is to conduct a pilot study before a possible randomized controlled multicenter trial whose final aim will be to examine whether a gratitude-based intervention in a palliative care setting can increase the quality of life and the quality of the relationship of patients and their caregivers and decrease their psychological distress and burden.

The specific aims of this pilot study are:

(i) to realize a cross-cultural translation of outcome measures that are not yet available in French (ii) to establish the feasibility of the study design (iii) to investigate the appropriateness of the gratitude concept and the gratitude-based intervention in the palliative care context, and finally (iv) to explore the sensitivity to change of our selected measures in order to calculate a sample size.

Procedure and measures:

Quantitative data will be collected at baseline (T0) and post-intervention (T1) with validated questionnaires. The intervention will last for one week. Five to ten days after T1, qualitative data will be collected from semi-structured interviews with the participants and from the content of the gratitude letters to explore their representations of the gratitude concept and their perception of the intervention.

The intervention includes the following steps:

1. Patients and caregivers recruitment: The clinical team (treating physician or advanced practice nurse) at each recruitment site will identify 10 patient-caregivers dyads. A research collaborator will then be in charge of giving information and get consent
2. Data collection at T0: Before the intervention, patients and their caregivers who agreed to participate will meet the research collaborator to fill quantitative questionnaires.
3. Intervention - 1-week duration: The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the participant (at least one of the patient or the caregiver) writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.
4. Data collection at T1: 5 to 10 days after the intervention itself, the patient and the caregiver, will meet with the research collaborator again to participate to a second quantitative assessment, similar to T0.
5. Qualitative assessment: 5 to 15 days after T1: This part is facultative. During the qualitative interviews, the following topics will be explored: their meanings of the term "gratitude"; experiences of gratitude; their experience of the intervention itself; obstacles and facilitators of the intervention; the impact of the intervention for themselves and for their relationship.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palliative Care

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

palliative care gratitude positive psychology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This clinical trial has a single arm: all the dyads will go through all the steps (apart from the qualitative assessment which are facultatives).
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gratitude intervention

The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.

Group Type EXPERIMENTAL

Gratitude intervention

Intervention Type BEHAVIORAL

The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gratitude intervention

The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

gratitude letter gratitude visit

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18
* progressive disease
* reduced life expectancy
* enrolment in palliative care
* stable state for the previous 24h assessed by the physician or the nurse in charge of the patient
* informed consent signed by patient
* For each patient, the identification of a close family or friend caregiver (fulfilling the below criteria\*) and who accepts to participate in the trial (by signing an informed consent)

In this research, a caregiver is defined as "a person who devotes time to help a family member or a friend affected in her/his health or autonomy. The caregiver assures, in a non-professional and regular way, a presence and a support to help her/him in his difficulties and assures her/his safety. The caregiver can be a friend, a family member or a neighbour" (Vaud canton definition). This definition will be the basis for the palliative patient to identify his caregiver.


* Age \>18
* Identified as the caregiver by the palliative patient (see above)
* prior agreement of the patient for the participation of the caregiver

Exclusion Criteria

* Person completely isolated socially, no family or friend caregiver identified
* Significant cognitive or psychiatric disorders which would affect the ability to give informed consent for this research
* Severe communication problems (foreign language, deafness, etc.).


* Psychiatric and cognitive disorders which would affect the ability to give informed consent for this research based on the information reported by the clinical team in charge of the patient and the personal evaluation of the research collaborator.
* Communication problems (foreign language, deafness, etc.).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mathieu BERNARD

Head of the Research Unit of the palliative and supportive care service

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathieu Bernard

Role: PRINCIPAL_INVESTIGATOR

Palliative and Supportive care service of the Centre Hospitalier Universitaire Vaudois

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rive-Neuve Foundation

Blonay, Canton of Vaud, Switzerland

Site Status

Lausanne University hospital, Palliative and supportive care service

Lausanne, Canton of Vaud, Switzerland

Site Status

Fribourg University hospital, Unité et Accueil de jour de soins palliatifs

Fribourg, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPBG2018-2020

Identifier Type: -

Identifier Source: org_study_id